Pre-op assessment should consider interactions between demographic and ocular factors

Article

Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism.

Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism. These conclusions were made by the authors of a study recently published in the Journal of Cataract & Refractive Surgery.

Researchers included 2991 eyes from 2991 myopic patients scheduled for LASIK to evaluate the influence of age, sex, ocular dominance, subjective cylinder and topographic astigmatism, subjective sphere and myopic pupil size on preexisting ocular residual astigmatism. A total of 46% of eyes had an ORA of 1.00 D or more.

Using ordinary least square estimations and odds ratios, researchers determined that negative predictors of the degree of preoperative ORA included subjective sphere, male sex and dominant eye, and that increasing age and larger mesopic pupils did not indicate ORA orientation. Further, with-the-rule astigmatism meridian was more likely to occur in eyes with low ORA, and oblique and against-the-rule meridians were related to high ORA.

To access this study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.